US · Healthcare

RetinalGenix Technologies Inc (RTGN)

Medical Devices

RetinalGenix Technologies Inc (RTGN) is listed on US in the Healthcare sector. Industry: Medical Devices. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RTGN

P/E ratio

18.00

RetinalGenix Technologies Inc (RTGN) — FAQ

What is RTGN's P/E ratio?

The price-to-earnings (P/E) ratio for RetinalGenix Technologies Inc (RTGN) is 18.00 (data as of 2026-05-23).

Does RetinalGenix Technologies Inc pay a dividend?

Dividend yield is not available in the current snapshot for RetinalGenix Technologies Inc (RTGN). Check the MyAverix Finance app for the latest dividend data.

What sector is RetinalGenix Technologies Inc in?

RetinalGenix Technologies Inc (RTGN) is classified in the Healthcare sector (Medical Devices industry).

What exchange is RTGN listed on?

RTGN is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)